Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Jagsonpal Pharmaceuticals has informed that the Nomination and Remuneration Committee has issued and allotted 31,040 Equity Shares of Rs. 5/- each under JPL ESOP 2022, to the eligible employee of the Company, upon exercise of vested options. These shares shall rank with the existing equity shares of the Company, in all respects. Consequent to the above allotment, the paid-up share capital of the Company has increased from Rs. 13,25,74,610 (constituting of 2,65,14,922 equity shares of Rs. 5/- each) to Rs. 13,27,29,810 (constituting of 2,65,45,962 equity shares of Rs. 5/- each). Details under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, is attached.
The above information is a part of company’s filings submitted to BSE.